Platinum Partner
EMD Serono
Website: https://www.emdserono.com/us-en
At EMD Serono, we’re committed to connecting important details within the fertility cycle. Thanks to our long-standing expertise, support programs, and partnerships, we aim to provide patients with solutions that can help ART treatment success.
To Learn more about our commitment to financial affordability and access for our fertility medications, please visit www.fertilitysavings.com.
To learn more about our fertility medication portfolio, please visit www.emdseronofertility.com.
Gold Partners
Bayer
Website: https://www.bayer.com/en/
Bayer is a recognized leader in the area of women’s healthcare, with a long-standing commitment to delivering science for a better life by advancing a portfolio of innovative treatments. Bayer offers a wide range of effective short- and long-acting birth control methods as well as therapies for menopause management and gynecological diseases. Bayer is also focusing on innovative options to address the unmet medical needs of women worldwide. Today, Bayer’s research and development efforts focus on finding new treatment options for menopause as well as gynecological diseases and includes several compounds in various stages of pre-clinical and clinical development. Together, these projects reflect the company’s approach to research, which prioritizes targets and pathways with the potential to alter the way that gynecological diseases are treated. Additionally, Bayer intends to provide 100 million women in low-and-middle income countries by 2030 with access to family planning by funding multi-stakeholder aid programs and by ensuring the supply of affordable modern contraceptives. This is part of the comprehensive sustainability measures and commitments from 2020 onwards and in line with the Sustainable Development Goals of the United Nations.
Mira
Website: https://www.miracare.com/
Mira is a San Francisco-based hormonal health company providing integrative care and hormonal testing for over 92,000 customers. In 2023, they were recognized by Inc. 5000 as America's fastest-growing femtech company.
Mira’s most important breakthrough was inventing the market's only FDA-compliant at-home fertility monitor with quantitative technology. Since the beginning, they have been on a mission to develop data-driven hormonal health solutions to help women make confident health decisions during every stage of their lives—from the menstrual stage to menopause.
Mira offers solutions to test, boost, and navigate fertility—starting from comprehensive hormone testing and supplements to fertility coaching and online courses. Unlike conventional at-home test kits, the Mira Hormone Monitor offers AI-powered personalized cycle insights by continuously monitoring four key hormone concentrations in urine samples. Mira’s certified lab test equips these insights with additional biomarkers, by offering personalized, one-on-one medical care and coaching to support every stage of their patients’ journeys with actionable steps. This type of test reveals a considerable amount of data, including a 6-day fertile window and ovulation day, and helps detect useful insights for people with hormone imbalances or signs of menopause. For those on a fertility journey, the Mira Hormone Monitor helped 84% of patients conceive during the first 6 cycles.
Plus, OB/GYNs, REIs, and Integrative and Functional medicine practitioners widely rely on Mira for continuous hormone data in addition to incorporating other standard-of-care measures, revolutionizing diagnostic decisions while lowering costs and improving outcomes. Mira leverages 11 million anonymous hormonal data points and 850,000 menstrual cycles to fill gaps in women’s healthcare and reveal how sex hormones affect broader health conditions to be ****better studied, diagnosed, and understood.
Naya Bioscience
Website: https://www.nayabiosciences.com/
With unprecedented rates of medical innovation, many biopharma companies and academic institutions are struggling to bring their products to market fast enough to realize their value.
NAYA Biosciences aims to address this challenge through an agile and synergistic platform, backed by access to capital and public markets & driven by experienced, entrepreneurial leadership.
Their unique business model is based on a portfolio approach, optimizing the risk-return investment profile through steady, scalable, profitable revenues augmented by the partnering upside of disruptive clinical-stage therapeutics.
Fueled by this value creation approach, they aim to continue their strategic acquisition of undervalued specialty assets, accelerate their clinical development and commercialization, and capitalize on their potential to transform patients’ lives.
Event Partner
Orrick
Orrick is a global law firm focused on serving the life sciences & healthtech, technology & innovation, energy & infrastructure and finance sectors. Clients worldwide call on our teams for forward-looking commercial advice on transactions, litigation and compliance matters. We bring distinctive quality, teamwork and value to the table – and innovate in everything we do.
Premier Research
Website: https://premier-research.com/womenshealth
Premier Research is a clinical research, product development, and consulting company dedicated to helping biotech, specialty pharma, and device innovators transform life-changing ideas and breakthrough science into new medical treatments. With more than 100 women’s health projects conducted in the last five years, Premier Research understands the complexities of developing novel therapeutics and diagnostics for conditions that exclusively or disproportionately affect women. We are supported by a network of thousands of highly experienced women’s health sites and offer end-to-end solutions for wherever you may be in your product development journey, from concept to commercialization.
Exhibitor
Restful Pump
Website: https://restfulpump.com/
Founded by a mom, for moms, Restful Pump’s mission is to improve the breast pumping
experience with the world’s first forward leaning, ergonomic, hands-free lactation systems.
Clinical research using randomized internally controlled study subjects increased total
breast milk expression with documented increased breast milk flow rates using The
Restful Pump® Chair.
For lactating moms experiencing sleep deprivation, exhaustion, chronic fatigue, and or
seeking postpartum restoration, there is a better way, even if a pump is worn inside the
bra. Offering corrective ergonomic positioning systems mitigates chronic strains from poor
postures, encourages relaxation and leaning forward facilitates gravity.
Using a breast pump to capture vital nutrients for infants unable to latch efficiently due to
tongue ties, lip ties, being a preemie or other medical complications, is a medical necessity.
Breast pumps are used 2-4x or even up to 10-12x a day! With caring for the family during
the day, working, and pumping in the middle of the night, when is Mom supposed to rest?
With Restful Pump®, we support busy, exhausted moms and care about the quality of life
for moms and their families.
Restful Pump® is addressing globally overlooked problems with simple, inexpensive
solutions. Now women can rest, unwind, or multitask in a supportive hands-free position,
using any type of breast pump. While providing comfort, convenience, and productivity,
our devices may even negate the need for baby formula by extending the breastfeeding
journey.
Our life changing patented/patent pending devices aim to dramatically improve the
efficacy and comfort of the breast pump experience, decrease medical expenses, increase
milk availability for NICU/NEC infants, expediting hospital discharge for new moms and
their infants. What formula shortage? We didn’t notice.
Restful Pump’s groundbreaking innovations will unequivocally and positively impact
maternal wellness and infant health. Because no one should (hypothetically) have PTSD
from seeing a breast pump and we can do better for ourselves and our babies, globally.
Solarea Bio
Website: https://solareabio.com/
Solarea Bio is a pioneering biotech company that harnesses natural, food-derived microbes to create innovative health solutions for chronic inflammatory conditions. As it enters the commercial stage, Solarea Bio is launching Journa™, a new consumer health brand, to bring its groundbreaking science to market. Journa's debut product, Bondia™, is a synbiotic medical food for the dietary management of bone loss associated with menopause, age and weight, demonstrating improvements in femur and hip bone density. Bondia is the first in a series of innovative microbe-powered products designed to address critical unmet needs in women’s health.
Venable LLP
Website: https://www.venable.com/
Venable LLP is an American Lawyer Global 100 law firm headquartered in Washington, DC that serves as primary counsel to a worldwide clientele of large and mid-sized organizations, nonprofits, high-net-worth entrepreneurs, and other individuals. With more than 850 professionals across the country, including in California, Colorado, Delaware, Florida, Illinois, Maryland, New York, Virginia, and Washington, DC, the firm strategically advances its clients' objectives in the United States and around the globe. Venable advises clients on a broad range of business and regulatory law, legislative affairs, complex litigation, and the full range of intellectual property disciplines. For more information, please visit https://www.venable.com/